131 related articles for article (PubMed ID: 19519589)
1. Dynamics of CD86 expression on allergic inflammation--new insights.
Pereira C; Tavares B; Loureiro G; Paiva A; Henriques A; Abrantes M; Machado D; Botelho F; Baganha MF
Recent Pat Inflamm Allergy Drug Discov; 2009 Jun; 3(2):128-31. PubMed ID: 19519589
[TBL] [Abstract][Full Text] [Related]
2. The CD28/CTLA-4-B7 signaling pathway is involved in both allergic sensitization and tolerance induction to orally administered peanut proteins.
van Wijk F; Nierkens S; de Jong W; Wehrens EJ; Boon L; van Kooten P; Knippels LM; Pieters R
J Immunol; 2007 Jun; 178(11):6894-900. PubMed ID: 17513738
[TBL] [Abstract][Full Text] [Related]
3. Accessory Molecule and Costimulation Requirements for CD4 T Cell Response.
Croft M; Dubey C
Crit Rev Immunol; 2017; 37(2-6):261-290. PubMed ID: 29773023
[TBL] [Abstract][Full Text] [Related]
4. Requirement of CD28-CD86 costimulation for allergen-specific T cell proliferation and cytokine expression.
Van Neerven RJ; Van de Pol MM; Van der Zee JS; Stiekema FE; De Boer M; Kapsenberg ML
Clin Exp Allergy; 1998 Jul; 28(7):808-16. PubMed ID: 9720814
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic T lymphocyte-associated antigen-4-Ig (CTLA-4-Ig) suppresses Staphylococcus aureus-induced CD80, CD86, and pro-inflammatory cytokine expression in human B cells.
Liu PC; Ssu CT; Tsao YP; Liou TL; Tsai CY; Chou CT; Chen MH; Leu CM
Arthritis Res Ther; 2020 Mar; 22(1):64. PubMed ID: 32228715
[TBL] [Abstract][Full Text] [Related]
6. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
[TBL] [Abstract][Full Text] [Related]
7. Costimulation light: activation of CD4+ T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile.
Broeren CP; Gray GS; Carreno BM; June CH
J Immunol; 2000 Dec; 165(12):6908-14. PubMed ID: 11120816
[TBL] [Abstract][Full Text] [Related]
8. Functional expression of a costimulatory B7.2 (CD86) protein on human salivary gland epithelial cells that interacts with the CD28 receptor, but has reduced binding to CTLA4.
Kapsogeorgou EK; Moutsopoulos HM; Manoussakis MN
J Immunol; 2001 Mar; 166(5):3107-13. PubMed ID: 11207262
[TBL] [Abstract][Full Text] [Related]
9. CTLA-4Ig: uses and future directions.
Ben-Shoshan M
Recent Pat Inflamm Allergy Drug Discov; 2009 Jun; 3(2):132-42. PubMed ID: 19519590
[TBL] [Abstract][Full Text] [Related]
10. B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets.
Yadav D; Judkowski V; Flodstrom-Tullberg M; Sterling L; Redmond WL; Sherman L; Sarvetnick N
J Immunol; 2004 Sep; 173(6):3631-9. PubMed ID: 15356107
[TBL] [Abstract][Full Text] [Related]
11. Modulation of experimental blood stage malaria through blockade of the B7/CD28 T-cell costimulatory pathway.
Taylor-Robinson AW; Smith EC
Immunology; 1999 Mar; 96(3):498-504. PubMed ID: 10233733
[TBL] [Abstract][Full Text] [Related]
12. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes.
Salomon B; Lenschow DJ; Rhee L; Ashourian N; Singh B; Sharpe A; Bluestone JA
Immunity; 2000 Apr; 12(4):431-40. PubMed ID: 10795741
[TBL] [Abstract][Full Text] [Related]
13. Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells.
Strainic MG; Liu J; Huang D; An F; Lalli PN; Muqim N; Shapiro VS; Dubyak GR; Heeger PS; Medof ME
Immunity; 2008 Mar; 28(3):425-35. PubMed ID: 18328742
[TBL] [Abstract][Full Text] [Related]
14. TCR Signaling and CD28/CTLA-4 Signaling Cooperatively Modulate T Regulatory Cell Homeostasis.
Holt MP; Punkosdy GA; Glass DD; Shevach EM
J Immunol; 2017 Feb; 198(4):1503-1511. PubMed ID: 28053234
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
[TBL] [Abstract][Full Text] [Related]
16. CTLA-4 engagement and regulatory CD4+CD25+ T cells independently control CD8+-mediated responses under costimulation blockade.
Coenen JJ; Koenen HJ; van Rijssen E; Boon L; Joosten I; Hilbrands LB
J Immunol; 2006 May; 176(9):5240-6. PubMed ID: 16621989
[TBL] [Abstract][Full Text] [Related]
17. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.
Liu Z; Geboes K; Hellings P; Maerten P; Heremans H; Vandenberghe P; Boon L; van Kooten P; Rutgeerts P; Ceuppens JL
J Immunol; 2001 Aug; 167(3):1830-8. PubMed ID: 11466409
[TBL] [Abstract][Full Text] [Related]
18. A costimulation-initiated signaling pathway regulates NFATc1 transcription in T lymphocytes.
Nurieva RI; Chuvpilo S; Wieder ED; Elkon KB; Locksley R; Serfling E; Dong C
J Immunol; 2007 Jul; 179(2):1096-103. PubMed ID: 17617602
[TBL] [Abstract][Full Text] [Related]
19. B lymphocyte alterations accompany abatacept resistance in new-onset type 1 diabetes.
Linsley PS; Greenbaum CJ; Speake C; Long SA; Dufort MJ
JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30830871
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD86 on human islet endothelial cells facilitates T cell adhesion and migration.
Lozanoska-Ochser B; Klein NJ; Huang GC; Alvarez RA; Peakman M
J Immunol; 2008 Nov; 181(9):6109-16. PubMed ID: 18941200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]